Labrecque L G, Barnes D M, Fentiman I S, Griffin B E
Department of Virology, Royal Postgraduate Medical School, Hammersmith Hospital, London, United Kingdom.
Cancer Res. 1995 Jan 1;55(1):39-45.
The human herpes virus Epstein-Barr (EBV) is clearly associated with African Burkitt's lymphoma and the undifferentiated from of nasopharyngeal carcinoma, although its role in oncogenesis is still poorly defined. Recently EBV has been implicated in other types of lymphomas, as well as in some nonlymphomatous neoplastic processes. Its possible association with human breast cancer has been investigated here. DNA from 91 cases of breast carcinoma and blood samples from the same patients were amplified with the PCR over a region in the EBV BamHIW major repeat sequence following a single-step amplification protocol. Nineteen samples (21%) were found to be positive; 10 samples of blood (only 3 of them from patients with EBV-positive tumors) were found by the adopted protocol to contain EBV DNA. Another series of PCR amplifications using primers covering a unique (nonreiterated) fragment in BamHIC encoding the EBERs (two short nonpolyadenylated RNAs generally highly expressed in cells latently infected with EBV) confirmed these findings. A good correlation between the two sets of experiments was observed, and only five differences in results were obtained on samples tested. In situ hybridization was carried out using BamHIW biotinylated DNA probes or EBER-1 digoxigenin-labeled riboprobes with the aim of confirming as well as localizing the signal to the epithelial cell. Twelve sections (63%) among the PCR-positive samples were found positive by in situ hybridization with the DNA probe, and six (31.5%) sections were found with the RNA probe. Twenty-one samples from benign breast tumors or normal breast tissue were used as controls for PCR amplification in this study, none of which was found positive. This is the first known report showing positive results for EBV in breast cancer. No statistical association was found in these studies between the presence of EBV and the histological type of the tumor, however. Its role therefore remains for the moment unknown, as well as does the significance of the association of EBV with only a subset of the cases.
人类疱疹病毒爱泼斯坦-巴尔病毒(EBV)与非洲伯基特淋巴瘤以及未分化型鼻咽癌明确相关,尽管其在肿瘤发生中的作用仍不明确。最近,EBV与其他类型的淋巴瘤以及一些非淋巴瘤性肿瘤过程也有牵连。本文对其与人类乳腺癌的可能关联进行了研究。按照单步扩增方案,用聚合酶链反应(PCR)对91例乳腺癌患者的DNA及其血液样本中EBV BamHIW主要重复序列区域进行扩增。发现19个样本(21%)呈阳性;按照所采用的方案,在10份血液样本中(其中只有3份来自EBV阳性肿瘤患者)检测到含有EBV DNA。使用覆盖BamHIC中一个编码EBERs(EBV潜伏感染细胞中通常高表达的两种短的非多聚腺苷酸化RNA)的独特(非重复)片段的引物进行的另一系列PCR扩增证实了这些结果。观察到两组实验之间有良好的相关性,在检测的样本上仅获得5个结果差异。使用生物素化的BamHIW DNA探针或地高辛配基标记的EBER-1核糖探针进行原位杂交,目的是确认信号并将其定位到上皮细胞。在PCR阳性样本中,12个切片(63%)经DNA探针原位杂交呈阳性,6个切片(31.5%)经RNA探针检测呈阳性。本研究使用21份来自乳腺良性肿瘤或正常乳腺组织的样本作为PCR扩增的对照,均未发现阳性。这是已知的首份显示EBV在乳腺癌中呈阳性结果的报告。然而,在这些研究中未发现EBV的存在与肿瘤的组织学类型之间存在统计学关联。因此,目前其作用仍然未知,EBV仅与部分病例相关联的意义也尚不清楚。